The purpose of this study is to investigate the safety and efficacy of the current hard gelatin capsule formulation of NRD135S.E1 80 mg once daily in the treatment of PDPN when administered for 13 weeks.
Age: 18 years - 66+
Gender: All
We've found 1 total result for "Peripheral Nervous System Diseases".